Drug profile · INN
dextrose
DEXTROSE 60% IN PLASTIC CONTAINER
dextrose (DEXTROSE 60% IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Drug details — dextrose
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 12
- Data quality
- 0.89
Quick answer
dextrose (DEXTROSE 60% IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is dextrose?
dextrose (DEXTROSE 60% IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
What is the brand name for dextrose?
DEXTROSE 60% IN PLASTIC CONTAINER is a marketed brand name for dextrose. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dextrose?
dextrose has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.